Evidence map›Paper›PMID 31269448›Full record

ArticleCell reports2019

The C-type Lectin Receptor CLEC12A Recognizes Plasmodial Hemozoin and Contributes to Cerebral Malaria Development.

Marie-Kristin Raulf, Timo Johannssen, Svea Matthiesen, Konstantin Neumann, Severin Hachenberg, Sabine Mayer-Lambertz, Fridolin Steinbeis, Jan Hegermann, Peter H Seeberger, Wolfgang Baumgärtner and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Synthetic Ligands of Myeloid C-Type Lectin Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Infection and immunity · 2026
    Article
  4. Investigation of carbohydrate-based molecules ofFrontiers in veterinary science · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. CLEC12A Binds toInternational journal of molecular sciences · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. From structure to function - Ligand recognition by myeloid C-type lectin receptors.Computational and structural biotechnology journal · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Marie-Kristin RaulfImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany; Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Timo JohannssenImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Brandenburg, Germany; Department of Biology, Chemistry and Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Svea MatthiesenImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Konstantin NeumannInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Bavaria, Germany; Institute of Clinical Chemistry, Hannover Medical School, 30625 Hannover, Lower Saxony, Germany.
Severin HachenbergImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Sabine Mayer-LambertzImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Fridolin SteinbeisDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Brandenburg, Germany; Charité-Universitätsmedizin Berlin, Klinik mit Schwerpunkt Infektiologie und Pneumologie, 13353 Berlin, Berlin, Germany.
Jan HegermannResearch Core Unit Electron Microscopy, Hannover Medical School, 30625 Hannover, Lower Saxony, Germany.
Peter H SeebergerDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Brandenburg, Germany; Department of Biology, Chemistry and Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Wolfgang BaumgärtnerDepartment of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Christina StrubeInstitute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany.
Jürgen RulandInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Bavaria, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Baden-Württemberg, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Bavaria, Germany.
Bernd LepeniesImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Lower Saxony, Germany; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Brandenburg, Germany; Department of Biology, Chemistry and Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany. Electronic address: bernd.lepenies@tiho-hannover.de.
University of Veterinary Medicine Hannover, Foundation · DEFreie Universität Berlin · DEKlinikum rechts der Isar · DEMax Planck Institute of Colloids and Interfaces · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria represents a major cause of death from infectious disease. Hemozoin is a Plasmodium-derived product that contributes to progression of cerebral malaria. However, there is a gap of knowledge regarding how hemozoin is recognized by innate immunity. Myeloid C-type lectin receptors (CLRs) encompass a family of carbohydrate-binding receptors that act as pattern recognition receptors in innate immunity. In the present study, we identify the CLR CLEC12A as a receptor for hemozoin. Dendritic cell-T cell co-culture assays indicate that the CLEC12A/hemozoin interaction enhances CD8

Indexed as

AnimalsCD8-Positive T-LymphocytesCross-PrimingDendritic CellsDisease Models, AnimalGranzymesHemeproteinsImmunity, InnateLectins, C-TypeMalaria, CerebralMiceMice, Inbred C57BLPlasmodium bergheiReceptors, MitogenT-LymphocytesCLEC12A protein, humanCLEC12A protein, mouseGranzymesHemeproteinshemozoinLectins, C-TypeReceptors, Mitogencerebral malariaC-type lectin receptorhemozoinMICL/CLEC12APlasmodium berghei

Identifiers

PMID31269448
PMCPMC6616648
OpenAlexW2954830614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.